# Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation

> **NCT00281554** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 254 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** RSD1235

## Key facts

- **NCT ID:** NCT00281554
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 254 (ACTUAL)
- **Last updated:** 2008-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00281554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00281554, "Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00281554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*